Brief: Roivant Sciences Q4 Net Income USD -182.496 Million
30/05/2024 12:00
May 30 (Reuters) - Roivant Sciences Q4 income from operations USD -266 million vs. IBES estimate USD -293.8 million. * Q4 operating expenses USD 294.93 million
Recent news on Roivant Sciences
See all newsU.S. STOCKS ON THE MOVE-Thermo Fisher, CME, Capital One, Northern Trust
Roivant rises as drug succeeds in two late-stage trials for eye disease
Immunovant falls after lupus drug setback
Brief: Roivant Announces Topline Results From Proof-Of-Concept Study Of Imvt-1402 In Cutaneous Lupus Erythematosus
U.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple